Halvard Bönig attended University in Dusseldorf, London and Memphis, Tennessee. He has a Master of Arts in literature and art history and a medical doctor with board certification as pediatrician and transfusionist. His chief scientific interests are translational cell and gene therapy and hematopoietic stem cells. He is currently a Professor for Translational Development of Cell and Gene Therapies at Goethe University, Frankfurt, Germany, as well as an Affiliate Professor of Hematology at the University of Washington in Seattle, Washington. Halvard has published more than 160 peer-reviewed research papers and serves on a couple of scientific journals’ editoral boards. He leads an academic GMP core unit which develops and manufactures cell and gene therapy medicines for clinical use.